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Varicella Zoster in Pregnancy 
See also Chicken Pox 
 
Background  
1. Definition  
o Varicella-zoster virus (VZV)  
 Causative agent of varicella (chickenpox) and herpes zoster (HZV or 
shingles) 
2. General info  
o Rarely, varicella causes problems in pregnancy for the mother and her 
unborn child 
o DNA virus 
o Member of Herpesvirus family 
 
Pathophysiology  
1. Pathology of disease  
o Varicella  
 Usually transmitted from nasopharyngeal mucosa of host to 
conjunctival or nasal/oral mucosa of recipient 
 Other mechanisms include:  
 Direct contact with vesicular fluids that contain virus  
 Airborne spread of the virus 
 Patients infectious 1-2 days prior to VZV exanthem until lesions are 
crusted over 
o Herpes Zoster  
 Virus remains latent in the dorsal root ganglia 
 May be reactivated 
 Often associated with impaired cell-mediated immunity 
o Site of VZV replication in fetus is unclear 
o Some suggest the fetus develops chickenpox in utero followed by resolution 
and subsequent infection of dorsal root ganglia 
2. Incidence, prevalence  
o 1-7 cases per 10,000 pregnancies
7
  
o Low incidence, largely related to immunity from prior infection, no revised 
estimates with increased availability of vaccine 
3. Risk factors  
o Childbearing women from subtropical and tropical areas (16% susceptible)  
o Highly communicable with secondary attack rates in susceptible household 
contacts approaching 90%, face to face contact with infected person for at 
least 5 minutes, contact indoors with case of chickenpox or herpes zoster for 
at least 1 hr
5,10
  
4. Morbidity / mortality  
o Varicella pneumonia in pregnancy is a medical emergency 
o Up to 14% mortality rate in untreated pregnant women with VZV 
pneumonia
5
  
o No significant increase in rates of spontaneous abortion and preterm birth 
with maternal VZV 
o Congenital varicella syndrome- dermatomal scarring, limb hypoplasia, low 
birth weight, cortical atrophy, mental retardation 
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o Risk of congenital varicella syndrome is small
3
  
 0.4% following exposure before 13 weeks gestation
3
  
 2% following exposure between 13-20 weeks gestation
3
  
 No congenital malformations have been observed when maternal 
infection occurs after 20 weeks, but neonatal skin lesions or scarring 
can be seen after birth 
o Neonatal varicella associated with 20-30% mortality rate
5
  
o Neonatal VZV fatality rate increased when symptoms of maternal infection 
occur less than five days prior to delivery  
o Due to development of maternal IgG and passive transfer of antibody 
protection to the neonate 
 
Diagnostics  
1. History  
o VZV  
 Incubation of chickenpox is 10-21 days
4
  
 Patients are infectious from 1 day before the rash until lesions are 
crusted 
 Prodrome of fever, malaise, and myalgia one to four days prior to the 
onset of rash 
 Varicella pneumonia in pregnancy: cough, dyspnea, fever, and 
tachypnea 
 VZV pneumonia usually develops within one week of rash 
 Varicella pneumonia may be more frequent, but not more severe in 
pregnancy 
o HZV  
 Fever, malaise, painful rash 
2. Physical exam  
o VZV  
 Vesicular rash of the superficial dermis, trunk, face, oropharynx and 
scalp  
 Several crops of vesicles may erupt every 2-3 days, lasting 6-10 days 
o HZV  
 Painful rash confined to dermatome 
3. Diagnostic testing  
o Dx usually clinical 
o Laboratory evaluation  
 Serologic tests may help document acute infection in confusing cases or 
indicate immunity 
 IgM antibody may be detected 3 days after VZV symptoms appear 
 IgG may be detected 7 days after varicella symptoms resolve 
 Serologic methods can identify VZV infection early in fetal 
development but cannot predict fetal sequelae 
o Diagnostic imaging  
 Prenatal diagnosis of fetal varicella infection is possible via serial 
ultrasounds which can detect limb abnormalities in affected fetuses  
 CXR finding in VZV pneumonia:  
 Bilateral diffuse peribronchial nodular infiltrates 
o Other studies  
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 Multiple antibody detection assays available:  
 Fluorescent anti-membrane antibody (FAMA) 
 Latex agglutination (LA) 
 Enzyme-linked immunosorbent assay (ELISA) 
 Complement fixation tests 
4. Diagnostic "Criteria"  
o Usually based on history of exposure and presence of rash 
o All pregnant women with primary varicella and any respiratory symptom 
should undergo CXR with abdominal shielding to confirm varicella 
pneumonia 
5. Recommendation (GRADE):  
o USPSTF has not completed a review of varicella in pregnancy or varicella 
immunization, however grade of recommendations are available from 
Australian Society of Infectious Diseases and the Royal College of 
Obstetricians and Gynecologists 
 
Differential Diagnosis  
1. Key DDx  
o Herpangina 
o Herpes Simplex 
o Meningococcemia 
2. Extensive DDx  
o Acute Nerve Injury 
o Impetigo 
o Meningitis 
o Meningococcal Infections 
o Pox Virus 
o Streptococcus Group A Infections 
 
Therapeutics  
1. Acute treatment  
o Check maternal antibody status 
o IgG seropositive  
 Reassurance 
o IgG seronegative  
 VariZIG within 24-96 hrs 
o Pregnant women infected with VZV should be offered supportive care:  
 Calamine lotion, antipyretics, and if necessary, systemic antipruritics 
 Oral acyclovir is safe in pregnancy and may decrease duration of illness 
if instituted within 24 hours of the rash, but does not prevent congenital 
infection 
o Some sources recommend treating all pregnant women with VZV infection 
with oral acyclovir
6
  
o HIV and immunocompromised pregnant women who are manifesting VZV 
infection or women with varicella pneumonia, require hospital admission for 
IV acyclovir
3
  
2. Further management (24 hrs)  
o 1st Trimester-counsel that the risk of congenital infection is 0.4%
3,8
  
o 2nd Trimester-counsel that risk of congenital infection is also low (2%)
3,8
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o 3rd Trimester  
 5-21 days prior to delivery-observe 
 4 days prior to delivery or 2 days postpartum:  
 Give VariZIG to mother and neonate, isolate either if signs of 
lesions  
 In acutely infected mothers if possible, delivery should be postponed 5-
7 days to prevent spread of VZV to neonate
3
  
3. Long-term care  
o 1st trimester  
 Observe mother for signs of pneumonia in first 24-48 hours after rash 
presents; consider treatment with acyclovir and prenatal diagnosis with 
ultrasound 
o If period of exposure is uncertain or delayed diagnosis-consider IgM and 
serial IgG testing 
4. Recommendation  
o ACOG recommends that non pregnant women of childbearing age should be 
asked about previous varicella infection at preconception visit and offered 
vaccination if no history of infection is elicited  
 
Follow-Up  
1. Return to office  
o Time frame for return visit: 
o 1-2 days after onset of rash to see if disease is progressing 
o -Recommendations for earlier follow-up: 
o SOB, cough, tachypnea 
2. Refer to specialist  
o Neurology-myelitis or encephalitis 
o ID-bacterial superinfection or viral resistance to acyclovir 
o Ophthalmology-ocular involvement 
o Dermatology-atypical rash 
o Perinatology-to co-manage 
3. Admit to hospital  
o If complications occur-pneumonia, ocular involvement 
o Admit and begin IV acyclovir for varicella pneumonia:  
 10-15 mg/kg x7 days with supportive care  
o Mortality rate for untreated varicella pneumonia can be as high as 40%
12
  
o IV acyclovir is also indicated for neurologic symptoms, hemorrhagic rash, 
continued fever, or appearance of new lesions after 6 days of treatment with 
oral acyclovir  
 
Prognosis  
1. Postherpetic neuralgia-most common complication of VZV infection 
2. Other complications include:  
o Bacterial superinfection of vesicles 
o Arthritis 
o Pneumonia-higher incidence in pregnancy approaching 20% 
o Glomerulonephritis 
o Myocarditis 
o Ocular disease 
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o Adrenal insufficiency 
o Death 
 
Prevention  
1. All women of reproductive age should be asked about history of disease at 
preconception visit 
2. Pregnant women who did not have childhood "chickenpox" (or do not recall having 
it) should be tested for serum VZV immunoglobulin IgG and offered VZIG 
within 72-96 hr postexposure at 1 vial per 10 kg of body weight to a maximum of 
five vials
4
  
3. If no previous illness and not pregnant women, should be offered Varivax, 2 doses, 
4-8 weeks apart
3
  
4. Prophylactic acyclovir, given 800 mg PO 5x daily for 5-7 days if started within 9 
days of exposure has also been shown to be effective at preventing VZV infection 
in children with an 85% reduction in infection
2
  
5. May consider combining therapies (acyclovir and VZIG) 
6. Varivax immunization during pregnancy is contraindicated11  
7. If vaccinated, women should avoid becoming pregnant for 1 month11  
8. Counseling is indicated if a pregnant woman is vaccinated-risk to fetus is small, not 
an indication for termination 
9. CDC has a registry for inadvertent vaccination in pregnancy 
10. Household members of pregnant women should still be vaccinated 
 
Patient Education 
1. Reassurance for women exposed to people with HZV  
o Infection only spread through direct contact with open lesions 
o Women should receive varicella vaccine at least 1 month before becoming 
pregnant 
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